Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01478932 · ClinicalTrials.gov registry record · NA
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01478932: Clinical Trial NA study, sponsored by University of Nebraska.
NCT01478932 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01478932, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to provide information on how the practicing of diaphragmatic breathing retraining (DBR) for 8-week at home may improve the health outcomes and encourage heart failure patients to engage in health-promoting activities by successfully controlling their shortness of breath (dyspnea).
Primary Outcome
Dyspnea rating scale of 0 to 4 (0 = none to 4 = extraordinary)
Interventions
- BEHAVIORAL Health Promotion
- BEHAVIORAL diaphragmatic breathing retraining
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-11-09 |
| Est. Completion | 2018-10-15 |
| Phase | NA |
Why NCT01478932 stopped before completion
NCT01478932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Health Promotion is the first listed.
NCT01478932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01478932 about?
NCT01478932 is a clinical study titled "Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes". The purpose of this study is to provide information on how the practicing of diaphragmatic breathing retraining (DBR) for 8-week at home may improve the health outcomes and encourage heart failure patients to engage in health-promoting activities by successfully controlling their shortness of breath...
What is the current status of trial NCT01478932?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2011-11-09. Estimated completion is 2018-10-15.
What interventions are being tested in trial NCT01478932?
The interventions under investigation include: Health Promotion (BEHAVIORAL), diaphragmatic breathing retraining (BEHAVIORAL).
Who is sponsoring clinical trial NCT01478932?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01478932's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI